Targeting Pleckstrin-2-Akt Signaling Reduces Proliferation in Myeloproliferative Neoplasm Models

Scientists identified first-in-class Plek2 inhibitors through an in silico high-throughput screening and cell-based assays followed by the synthesis of analogs. The Plek2-specific small molecule inhibitors showed potent inhibitory effects on cell proliferation.